Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

NCT05715281 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

NIH

Sponsor class

Conditions

Advanced Rare Malignant Solid Neoplasm
Rare Malignant Solid Neoplasm
Refractory Rare Malignant Solid Neoplasm

Interventions

BIOLOGICAL: Atezolizumab
PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography Test
DRUG: Tiragolumab

Sponsor

National Cancer Institute (NCI)